Management of cutaneous side effects of cetuximab therapy with vitamin K1 crème
Ocvirk, Janja, Rebersek, Martina
Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab – real-world experience
Hribernik, Nezka, Boc, Marko, Ocvirk, Janja, Knez-Arbeiter, Jasna, Mesti, Tanja, Ignjatovic, Marija, Rebersek, Martina
Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience
Ocvirk, Janja, Moltara, Maja Ebert, Mesti, Tanja, Boc, Marko, Rebersek, Martina, Volk, Neva, Benedik, Jernej, Hlebanja, Zvezdana
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
Rebersek, Martina, Mesti, Tanja, Boc, Marko, Ocvirk, Janja
Determination of copper and other trace elements in serum samples from patients with biliary tract cancers: prospective noninterventional nonrandomized clinical study protocol
Rebersek, Martina, Hribernik, Nezka, Markovic, Katarina, Markovic, Stefan, Valentinuzzi, Katja Ursic, Cemazar, Maja, Zuliani, Tea, Milacic, Radmila, Scancar, Janez
Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study
Hribernik, Nezka, Strasek, Katja, Huff, Daniel T, Studen, Andrej, Zevnik, Katarina, Skalic, Katja, Jeraj, Robert, Rebersek, Martina
Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis
Rebersek, Martina, Boc, Marko, Cerkovnik, Petra, Benedik, Jernej, Hlebanja, Zvezdana, Volk, Neva, Novakovic, Srdjan, Ocvirk, Janja
Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma
Ocvirk, Janja, Boc, Marko, Rebersek, Martina, Ros, Tanja
Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy
Hribernik, Nezka, Strasek, Katja, Studen, Andrej, Zevnik, Katarina, Skalic, Katja, Jeraj, Robert, Rebersek, Martina
Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision
Rebersek, Martina
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Mesti, Tanja, Ebert Moltara, Maja, Boc, Marko, Rebersek, Martina, Ocvirk, Janja
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
Moltara, Maja Ebert, Novakovic, Srdjan, Boc, Marko, Bucic, Marina, Rebersek, Martina, Zadnik, Vesna, Ocvirk, Janja